Liquid Embolic Agent Market

The liquid embolic agents market consists of minimally invasive solutions used to treat neurovascular conditions like aneurysms and arteriovenous malformations (AVMs). The primary customers are hospitals, specialty clinics, and ambulatory surgical centers that employ skilled specialists such as interventional neuroradiologists. Key growth drivers include the rising prevalence of neurovascular diseases, technological innovations in intervention devices, and supportive reimbursement policies.